Sabba Stephen L's Form 4 filing
Ligand Pharmaceuticals Inc (LGND) · filed Mar 25, 2026
- Accession no.
- 0001104659-26-034308
- Filed
- Mar 25, 2026
- Trade date
- Mar 23, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $207.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sabba Stephen LCIK 0001442372 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Common Stock | SSaleDisposed | −1,000 | $207.87 | −$207,870 | 32,793 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.